Disclosure Information

Financial disclosure information is current as of January 2015 and forward. Information is limited to financial relationships with commercial entities that have products in the field of hepatitis C. AASLD defines a direct financial relationship requiring disclosure as a compensated relationship with a company, by an individual, that should generate an IRS Form W2-1099.

Current Chairs

Andrew I. Aronsohn, MD

Personal Financial Relationships: None

Institutional Research: None

Updated: 10/24/2022

Debika Bhattacharya, MD

Personal Financial Relationships: None

Institutional Research: Dr. Bhattacharya was awarded research grants, paid to her institution, from Gilead Sciences Inc.

Updated: 10/24/2022

Vincent Lo Re, MD, MSCE

Personal Financial Relationships: None

Institutional Research: None

Updated: 10/24/2022

Jennifer C. Price, MD, PhD

Personal Financial Relationships: None

Institutional Research: Dr. Price was awarded research grants, paid to her institution, from Gilead Sciences Inc. and Merck & Co Inc. Spouse has interest in stock that is independently managed in AbbVie, Bristol-Myers Squibb, Johnson and Johnson, Merck.

Updated: 10/24/2022

Current Panel Members

Jordan J. Feld, MD, MPH

Personal Financial Relationships: Dr. Feld serves as a scientific consultant to AbbVie, Antios, Arbutus, BluejayTherapeutics, Deep Genomics, Finch, Gilead, GSK, Janssen.

Institutional Research: Dr. Feld was awarded research grants paid to his institution from AbbVie, Alexion, Altimmune, Eiger, Enanta, Gilead, GSK, Janssen, Wako/Fujifilm.

Updated: 10/24/2022

Theo Heller, MD

Personal Financial Relationships: None

Institutional Research: None

Updated: 10/24/2022

Ravi Jhaveri MD, FIDSA, FPIDS, FAAP

Personal Financial Relationships: Dr. Jhaveri serves as a consultant for MedImmune/AstraZeneca,Seqirus and Dynavax. He also receives an editorial stipend from Elsevier.

Institutional Research: Dr. Jhaveri received research grants, paid to his institution, from AbbVie, Inc., and Gilead Sciences, Inc.

Updated: 10/24/2022

H. Nina Kim, MD MSc

Personal Financial Relationships:

Institutional Research:

Updated: 10/24/2022

Jennifer J. Kiser, PharmD, PhD

Personal Financial Relationships: None

Institutional Research: Dr. Kiser was awarded research grants, paid to her institution, from Gilead Sciences, Inc.

Updated: 10/24/2022

Tatyana Kushner, MD, MSCE

Personal Financial Relationships:

Institutional Research:

Updated: 10/24/2022

Joseph K. Lim, M.D.

Personal Financial Relationships:

Institutional Research:

Updated: 10/24/2022

Benjamin P. Linas, MD, MPH

Personal Financial Relationships: None

Institutional Research: None

Updated: 10/24/2022

Ponni Perumalswami, MD

Personal Financial Relationships:

Institutional Research:

Updated: 10/24/2022

Andrew Reynolds

Personal Financial Relationships: None

Institutional Research: Mr. Reynolds’s organization was awarded educational grants from AbbVie, Inc., and Gilead Sciences, Inc.

Updated: 10/24/2022

Gloria Searson, ACSW

Personal Financial Relationships: None

Institutional Research: Ms. Searson's organization was awarded grants from AbbVie, Inc., Gilead Sciences, Inc, and Merck & Co, Inc.

Updated: 10/24/2022

Philip Spradling, MD **+

Personal Financial Relationships: None

Institutional Research: None

Updated: 10/24/2022

Norah A. Terrault, MD

Personal Financial Relationships: Dr. Terrault serves on the data safety monitoring board of Moderna(ceased as of April 2022).

Institutional Research: Dr. Terrault was awarded research grants, paid to her institution, from Gilead Sciences, GSK, Roche-Genentech, Helio Health

Updated: 10/24/2022